Equities

Nutex Health Inc

NUTX:NAQ

Nutex Health Inc

Actions
TechnologyTechnology
  • Price (USD)25.17
  • Today's Change0.31 / 1.25%
  • Shares traded94.39k
  • 1 Year change-21.22%
  • Beta0.0859
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments223415
Total Receivables, Net63582.08
Total Inventory3.393.53--
Prepaid expenses2.681.870.30
Other current assets, total------
Total current assets919818
Property, plant & equipment, net2692950.11
Goodwill, net171757
Intangibles, net212111
Long term investments----0
Note receivable - long term------
Other long term assets0.430.42--
Total assets39843286
LIABILITIES
Accounts payable2528--
Accrued expenses157.940.20
Notes payable/short-term debt3.372.620
Current portion long-term debt/capital leases15174.63
Other current liabilities, total----0.30
Total current liabilities58558.64
Total long term debt2402270.15
Total debt2592464.78
Deferred income tax5.15101.75
Minority interest18240.00
Other liabilities, total15190.06
Total liabilities33733611
SHAREHOLDERS EQUITY
Common stock0.680.650.05
Additional paid-in capital470458107
Retained earnings (accumulated deficit)(409)(363)(32)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity619675
Total liabilities & shareholders' equity39843286
Total common shares outstanding4.514.340.32
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.